ArticleLeukemia2017

NK cell dynamics and association with molecular response in early chronic phase chronic myelogenous leukemia (CML-CP) patients treated with nilotinib.

S Sopper et al.PubMed ↗Publisher ↗

No numbers read from the abstract.